openPR Logo
Press release

Oncology to lead the global biopharmaceutical contract manufacturing market by therapeutic area

08-01-2018 12:42 PM CET | Health & Medicine

Press release from: Future Market Insights

Oncology to lead the global biopharmaceutical contract

A new study on the global biopharmaceutical contract manufacturing market by Future Market Insights discusses some interesting aspects of the differentiating strategies of key market players. Top biomanufacturing companies in North America and Europe are focussing on market collaborations and agreements as key business strategies for growth and expansion across the globe. These companies are also acquiring small scale biopharmaceuticals companies in the Asia Pacific region to strengthen their market presence. Future Market Insights presents several useful insights and a comprehensive revenue forecast of the global biopharmaceutical contract manufacturing market in a new report titled “Biopharmaceutical Contract Manufacturing Market: Global Industry Analysis 2012–2016 and Opportunity Assessment 2017–2027” along with information on the factors influencing revenue growth of the market over a 10 year assessment period from 2017 to 2027.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-2982

The global biopharmaceutical contract manufacturing market is estimated to be valued at US$ 5,625.0 Mn by the end of 2017 and this is expected to increase to US$ 15,467.8 Mn by the end of 2027, registering a CAGR of 10.6% in terms of value over the forecast period.

Global Biopharmaceutical Contract Manufacturing Market: Regional Forecast

The global biopharmaceutical contract manufacturing market has been studied across the key regions of North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa. North America is the largest regional market, estimated to be valued at US$ 5,039.3 Mn by 2027 end, with a CAGR of 9.8%. APEJ is the second largest market for biopharmaceutical contract manufacturing, with a growth rate of 12.2% anticipated during the 10 year forecast period.

Global Biopharmaceutical Contract Manufacturing Market: Forecast by Platform

The report segments the global biopharmaceutical contract manufacturing market on the basis of Platform into Mammalian and Microbial. Mammalian is the largest segment by platform, which is estimated to represent US$ 3,857.2 Mn or 68.6% share of the total market in 2017 and is projected to reach US$ 12,534.5 Mn or 81.0% share by 2027 end, expanding at a CAGR of 12.5% over the forecast period.

Global Biopharmaceutical Contract Manufacturing Market: Forecast by Product Type

In terms of product type, the global biopharmaceutical contract manufacturing market is segmented into Growth Factors, Interferons, Monoclonal Antibodies, Recombinant Hormones, Vaccines, Insulin, and Others. Monoclonal Antibodies is the largest segment by product type, with revenues estimated to cross US$ 8,100 Mn by the end of the forecast period and a CAGR of 11.3%.

Global Biopharmaceutical Contract Manufacturing Market: Forecast by Application

The global biopharmaceutical contract manufacturing market is segmented on the basis of application into Clinical and Commercial. The Commercial segment will dominate the global market, with revenues in excess of US$ 12,000 Mn expected to be recorded by the end of 2027 resulting in a CAGR of 11.0%.

Global Biopharmaceutical Contract Manufacturing Market: Forecast by Therapeutic Area

On the basis of therapeutic area, the global biopharmaceutical contract manufacturing market is segmented into Autoimmune Diseases, Oncology, Metabolic Diseases, Ophthalmology, Cardiovascular Diseases, Infectious Diseases, Neurology, Respiratory Disorders, and Others. Oncology is the largest segment by therapeutic area, expected to be valued at US$ 1,111.1 Mn by the end of 2017. Oncology is also the most lucrative segment. Autoimmune Diseases is the second largest segment by therapeutic area with a market attractiveness index of 1.3.

To view TOC of this report is available upon request @ https://www.futuremarketinsights.com/askus/rep-gb-2982

Global Biopharmaceutical Contract Manufacturing Market: Competitive Landscape

The report features some of the leading companies operating in the global biopharmaceutical contract manufacturing market. Companies profiled include Lonza Group AG, Baxter Biopharma Solutions, Samsung Biologics Co., Ltd., Fujifilm Diosynth Biotechnologies, Boehringer Ingelheim GmbH, Patheon N.V., Rentschler Biotechnologie GmbH, Biomeva GmbH, Probiogen AG, Cytovance Biologics, Inc., KBI Biopharma, Inc., WuXi Biologics, Abzena Plc, Vetter Pharma International GmbH, Sandoz International GmbH, Catalent, Inc., AbbVie Contract Manufacturing (An AbbVie Company), Ajinomoto Althea, Inc.

About Us
Future Market Insights is the premier provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in London, the global financial capital, and has delivery centres in the U.S. and India.

FMI’s research and consulting services help businesses around the globe navigate the challenges in a rapidly evolving marketplace with confidence and clarity. Our customised and syndicated market research reports deliver actionable insights that drive sustainable growth. We continuously track emerging trends and events in a broad range of end industries to ensure our clients prepare for the evolving needs of their consumers.

Contact Us
U.S. Office
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
F: +1-845-579-5705
Email: sales@futuremarketinsights.com
Web:https://www.futuremarketinsights.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology to lead the global biopharmaceutical contract manufacturing market by therapeutic area here

News-ID: 1156588 • Views:

More Releases from Future Market Insights

Aerospace Fluid Conveyance System Market to Reach USD 4.3 Billion by 2035 with Innovative Components and Growth
Aerospace Fluid Conveyance System Market to Reach USD 4.3 Billion by 2035 with I …
The global Aerospace Fluid Conveyance System Market is witnessing steady growth, driven by the increasing demand for advanced fluid handling solutions across commercial and military aircraft. Valued at USD 3.1 billion in 2025, the market is projected to reach USD 4.3 billion by 2035, registering a healthy CAGR of 3.4%. Both established and emerging manufacturers are actively innovating to meet the evolving needs of the aviation sector. Market Dynamics and Growth
Automotive Starter and Alternator Market to Reach USD 45.4 Billion by 2035 Amid Electrification Trends
Automotive Starter and Alternator Market to Reach USD 45.4 Billion by 2035 Amid …
The global Automotive Starter and Alternator Market is on track for substantial expansion, driven by rapid advancements in vehicle technology and the growing focus on electrification. Valued at USD 29.3 billion in 2025, the market is projected to reach USD 45.4 billion by 2035, registering a CAGR of 4.5% during the forecast period. The growth reflects the automotive industry's continuous evolution toward fuel-efficient and sustainable systems that integrate reliability, performance,
Connected Aircraft Market Soars to USD 63.6 Billion by 2035, Driven by Connectivity and Digital Innovation
Connected Aircraft Market Soars to USD 63.6 Billion by 2035, Driven by Connectiv …
The global Connected Aircraft Market is poised for transformative growth, projected to rise from USD 6.8 billion in 2025 to USD 63.6 billion by 2035, registering an impressive CAGR of 25.1% over the forecast period. This surge is being fueled by airlines' growing focus on enhancing operational efficiency, passenger experience, and safety through advanced connectivity solutions. Industry leaders such as Honeywell International Inc., Thales Group, Raytheon Technologies Corporation, BAE Systems PLC,
Slingshot/3-Wheeled Motorcycle Market Set to Hit USD 1.8 Billion by 2035 Driven by Design and Innovation
Slingshot/3-Wheeled Motorcycle Market Set to Hit USD 1.8 Billion by 2035 Driven …
The global Slingshot/3-Wheeled Motorcycle Market is on track to witness sustained growth, driven by shifting consumer lifestyles, urban mobility trends, and a rising interest in alternative transportation. Valued at USD 1.3 billion in 2025, the market is projected to reach USD 1.8 billion by 2035, expanding at a CAGR of 2.9%. During the early growth phase (2021-2025), the market experiences gradual expansion, fueled by consumers' growing appetite for distinctive vehicles that

All 5 Releases


More Releases for Biopharma

Biopharma Outsourcing Market to See Massive Growth by 2029 | Keyrus Biopharma, E …
According to HTF Market Intelligence, the Global Biopharma Outsourcing market to witness a CAGR of 10.68% during the forecast period (2023-2029). The Latest Released Biopharma Outsourcing Market Research assesses the future growth potential of the Biopharma Outsourcing market and provides information and useful statistics on market structure and size. This report aims to provide market intelligence and strategic insights to help decision-makers make sound investment decisions and identify potential gaps and
Global Biopharma Outsourcing Market 2022 Future Set to Massive Growth | Major Pl …
The "Global Biopharma Outsourcing Market Analysis to 2030" is a particular and top to bottom analysis of the Biopharma Outsourcing industry with an emphasis on the worldwide market trend. The report expects to provide an overview of worldwide Biopharma Outsourcing market detailed market segmentation by service, organization mode, application and geography. The worldwide Biopharma Outsourcing market is predictable to witness high growth during the forecast period. The report gives key
Biopharma Outsourcing Global Market Outlook - BioPharma Services, Lambda Therape …
The Biopharma Outsourcing Market Perspective, Comprehensive Analysis along with Major Segments and Forecast, 2020-2026. The Biopharma Outsourcing market report is a valuable source of data for business strategists. It provides the industry overview with market growth analysis with a historical & futuristic perspective for the following parameters; cost, revenue, demands, and supply data (as applicable). The report explores the current outlook in global and key regions from the perspective of
Biopharma Outsourcing Market Outlook to 2025: Sartorius, Emcure Pharmaceuticals, …
Biopharma Outsourcing market is also presented to the readers as a holistic snapshot of the competitive landscape within the given forecast period. The report also educates about the market strategies that are being adopted by your competitors and leading organizations. The report also focuses on all the recent industry trends. It presents a comparative detailed analysis of the all regional and player segments, offering readers a better knowledge of where
Biopharma Outsourcing Market Future Analysis to 2023 |Sartorius, Emcure Pharmace …
According to the Biopharma Outsourcing Market report, the global market is expected to witness a relatively higher growth rate during the forecast period. This Biopharma Outsourcing Market Report cover strategic profiling of key players in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market. This study also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and
Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 …
WiseGuyReports.Com Publish a New Market Research Report On –“ Biopharma Outsourcing 2018 Global Market SWOT Analysis and Opportunities To 2023 | Key Players : Sartorius, Emcure Pharmaceuticals, BioPharma Services, Baxter Healthcare, Keyrus Biopharma, Quintiles”. Description:- Biopharma outsourcing plays an important role in the growth of biopharmaceuticals market. The growth of this market is promising with rapidly expanding biosimilars base. Scope of the Report: This market encompasses various contract companies that provide clinical trials, drug